Veliparib with carboplatin and paclitaxel in frontline high-grade serous ovarian cancer (HGSOC): Efficacy and safety of paclitaxel weekly and every 3 weeks in the VELIA study Meeting Abstract
| Authors: | Okamoto, A.; Fleming, G.; Bookman, M.; Brady, M. F.; Swisher, E. M.; Steffensen, K. D.; Cloven, N. G.; Enomoto, T.; O'Malley, D. M.; Van Le, L.; Tewari, K. S.; Barlin, J. N.; Bradley, W.; Moore, K. N.; Chan, J.; Wu, M.; Hashiba, H.; Dinh, M. H.; Coleman, R. L.; Aghajanian, C. |
| Abstract Title: | Veliparib with carboplatin and paclitaxel in frontline high-grade serous ovarian cancer (HGSOC): Efficacy and safety of paclitaxel weekly and every 3 weeks in the VELIA study |
| Meeting Title: | ESMO Virtual Congress 2020 |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Sep 19-21/Oct 16-18 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-09-01 |
| Start Page: | S618 |
| Language: | English |
| ACCESSION: | WOS:000573469101106 |
| DOI: | 10.1016/j.annonc.2020.08.957 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 818P -- Source: Wos |
